ProPharma Group Announces Acquisition of Clinical Safety Company, Drug Safety Solutions
Overland Park, KS — ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Drug Safety Solutions, a clinical safety company based in Reunion, Florida. Drug Safety Solutions’ clinical safety team and operations will join ProPharma Group’s existing pharmacovigilance and medical information operations, resulting in a comprehensive service portfolio to meet the clinical and postmarketing needs of pharmaceutical and biotech companies.
“Drug Safety Solutions has long been a trusted provider in the clinical safety space, and we are very excited to welcome them to the ProPharma Group team. The combination of our services and expert staff will significantly enhance the pharmacovigilance services we are able to provide to our clients,” commented Jeff Hargroves, CEO of ProPharma Group.
Established in 1998, Drug Safety Solutions’ has provided pharmacovigilance, medical monitoring and data safety monitoring board services for sponsors and clinical research organizations through all phases of clinical trials. Following the acquisition, CEO Gil Price will join ProPharma Group in the role of Chief Medical Officer. Speaking on the acquisition, Dr. Price stated, “I am very excited about the value this joining of services will bring to our clients, and look forward to the future growth this opportunity will provide to both our clients and our colleagues.”
This strategic move to expand our clinical safety services further positions ProPharma Group as the partner of choice for pharmaceutical and biotechnology companies around the world.
About ProPharma Group
ProPharma Group, a portfolio company of Linden Capital Partners, is a global industry leader in comprehensive compliance services that span the entire lifecycle of drugs, biologics, and devices. ProPharma Group has more than 650 colleagues around the world providing medical information and pharmacovigilance services as well as other compliance-related services. ProPharma Group is your partner, everywhere.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.